Isolation of Salivary Epithelial Cells from Human Salivary Glands for In Vitro Growth as Salispheres or Monolayers

Summary

We present a method for isolating and cultivating primary human salivary gland-derived epithelial cells. These cells exhibit gene expression patterns consistent with them being of salivary epithelial origin and can be grown as salispheres on basement membrane matrices derived from Engelbreth-Holm-Swarm tumor cells or as monolayers on treated culture dishes.

Abstract

The salivary glands are a site of significant interest for researchers interested in multiple aspects of human disease. One goal of researchers is to restore function of glands damaged by radiation therapies or due to pathologies associated with Sjögren's syndrome. A second goal of researchers is to define the mechanisms by which viruses replicate within glandular tissue where they can then gain access to salivary fluids important for horizontal transmission. These goals highlight the need for a robust and accessible in vitro salivary gland model that can be utilized by researchers interested in the above mentioned as well as related research areas. Here we discuss a simple protocol to isolate epithelial cells from human salivary glands and propagate them in vitro. Our protocol can be further optimized to meet the needs of individual studies. Briefly, salivary tissue is mechanically and enzymatically separated to isolate single cells or small clusters of cells. Selection for epithelial cells occurs by plating onto a basement membrane matrix in the presence of media optimized to promote epithelial cell growth. These resulting cultures can be maintained as three-dimensional clusters, termed "salispheres", or grown as a monolayer on treated plastic tissue culture dishes. This protocol results in the outgrowth of a heterogenous population of mainly epithelial cells that can be propagated for 5-8 passages (15-20 population doublings) before undergoing cellular senescence.

Introduction

In mammals the salivary glands are organized into 3 pairs of major salivary glands: the parotid, submandibular, and sublingual glands. There also exists a series of minor glands located on the tongue and scattered throughout the oral cavity¹. The major glands are responsible for the bulk volume of saliva produced². In addition to providing antimicrobial protection through secreted factors, the saliva is important in the process of chewing and lubricating food as it passes through the esophagus². As such, salivary gland dysfunction represents a medical issue where sufferers who are unable to produce enough saliva are more prone to developing maladies such as dental cavities or oral candidiasis³. Additionally, reduced saliva results in greater difficulty eating and digesting food having a significant impact on quality of life.

Salivary gland dysfunction is primarily found in patients suffering from Sjögren's syndrome, an autoimmune disorder, or in patients with head and neck cancer who have undergone irradiation therapy^3,4,5,6. Damaged secretory acini within the glands as a result of autoimmunity or radiation therapy do not undergo self-renewal, which results in a patient living with irreversible damage⁶. The study of salivary glands has also garnered the attention or researchers interested in mechanisms of viral pathogenesis. Some pathogens, such as human cytomegalovirus (HCMV), persistently replicate within the salivary glands, which then allows for transmission of nascent virus to a new host via saliva^7,8. Thus, there is an unmet need to develop robust and reproducible in vitro models of salivary gland tissue to tackle and understand a diverse array of medical problems.

Several models of the murine salivary gland system have been used as a starting point to understand and characterize the different epithelial cells that form the salivary glands^9,10. There exist obvious and major differences between human and murine salivary glands¹¹. Most notably the human parotid gland is larger in relation to the submandibular gland whereas the mouse submandibular and parotid are much similar in size^1,2,11. While immortalized human submandibular cell lines exists, there are major concerns that the immortalized cells do not accurately maintain the phenotype of the primary tissue and secondary concerns that the immortalized cells are not actually derived from salivary epithelium itself¹². For these reasons there is an interest and a need to study primary salivary tissue from humans.

Here we describe a protocol to isolate primary epithelial cells from human salivary glands for tissue culture. Our protocol is based on the works of Pringle et al. and Tran et al. with modifications made to generally simplify their procedures^13,14. First, while Tran et al.'s protocol calls for a long five-hour incubation for enzymatically digesting the salivary tissue, our modified protocol has been successful with as little as one-hour incubation, similar to that in Pringle et al. Second, we use different enzymes for tissue digestion, most notably we don't use trypsin as is used in the original Tran et al. protocol, but instead use a mixture of dispase and collagenase. We prefer to avoid trypsin in the initial digestion steps as a recent study suggested that initial digestion of the salivary tissue by trypsin results in reduced cell viability, possibly by the loss of a rare stem cell population¹⁵. Lastly, we culture the salispheres on the surface of basement membrane matrix (BMM) using a commercially available media originally formulated for the propagation of bronchial epithelial cells. Our protocol can be used to isolate salivary cells from parotid, submandibular, and sublingual glands. These cells express salivary amylase and other salivary specific genes indicating that they maintain a phenotype similar to that of salivary acinar epithelial cells⁷. We have successfully generated salivary cultures from >50 primary human tissue samples using this methodology. Moreover, the primary salivary cells can easily be cryopreserved for use at a later date.

Protocol

These protocols and studies have been reviewed and approved by the Institutional Review Board at the University of Cincinnati (Federal-wide Assurance #00003152, IRB protocol 2016-4183). Salivary tissue is commonly resected in many head and neck surgical procedures and is usually uninvolved by the malignant process. Typically, freshly resected salivary gland tissue is used within 2-4 h after removal from the patient (Figure 1A).

1. Reagent Preparation

1. Bronchial epithelial cell growth medium (BEGM)
   1. Add components from the kit provided by manufacturer (see the Table of Materials).
   2. Wash each tube once with the base media to ensure full transfer of components. Then add charcoal stripped fetal bovine serum to make a final concentration of 4% serum.
2. Red blood cell (RBC) lysis buffer
   1. To make 10x stock, add 40.15 g of NH₄Cl, 5.0 g of NaHCO₃, and 0.186 g of ethylenediaminetetraacetic acid (EDTA) and bring up to a final volume of 200 mL using dH₂O. Then filter sterilize and store at 4 °C.
   2. Dilute to a working concentration of 1x in sterile dH₂O prior to use.
3. Dissociation solution
   1. To a 100 mL bottle of dispase solution (see the Table of Materials) add 0.15 g of collagenase type III. After collagenase has fully dissolved, filter sterilize the new solution and aliquot. Store at -20 °C.

2. Tissue Digestion

1. Using a 100 mm tissue culture plate, mechanicallymince the tissue into fine pieces ~1-2 mm in size using autoclave-sterilized dissecting scissors and surgical forceps (Figure 1B,C). Connective tissue between pieces should be cut to ensure proper separation and ease in further steps.
2. Add 6 mL of the dispase/collagenase solution to the minced tissue. Then incubate at 37 °C for approximately 30 min to 1 h.
3. Disrupt the tissue by pipetting with a 5 mL serological pipette 15-20 times.
4. Incubate at 37 °C for another 30 min to 1 h.
5. Repeat steps 2.3 and 2.4 two-three more times or until the tissue resembles a slurry and can easily pass through the pipette opening (Figure 1D).
   NOTE: The starting size of the tissue specimen and how fineness of the tissue mincing will determine how many times one needs to repeat steps 2.3 and 2.4. Typically, we receive tissue approximately 1 cm x 1 cm in size. Additionally, one can monitor tissue dissociation using a standard inverted tissue culture microscope to track the progress of cell dissociation from the tissue. Small clusters of cells are ideal for initial outgrowth of salivary cells as salispheres.

3. Coating wells with basement membrane matrix

NOTE: Basement membrane matrix (BMM) should be thawed overnight at 4 °C the day before it will be used. Once thawed, BMM should be constantly maintained on ice or at 4 °C as it will rapidly solidify (i.e., form a gel) at warmer temperatures. Additionally, care should be taken if samples have been chilled on ice prior to plating on BMM as cold samples will "melt" the BMM and expose cells to the plastic dish.

1. Slowly pipette BMM (see the Table of Materials) into each well to be coated. Evenly and slowly distribute the BMM over the well.
   ​NOTE: Generally, we use 500 µL per each well of a six-well plate, but this volume can be adjusted for use on other variants of plates such as 12-well or 24-well, or as desired for thicker or thinner hydrogels.
2. Incubate the coated plates at 37 °C for at least 15 min prior to use to allow the BMM time to solidify.

4. Filtering of undigested tissue, RBC lysis, and cell plating

1. Transfer tissue homogenate from step 2.5 to a 15 mL conical tube. Wash plate once with 6 mL of Dulbecco's phosphate buffered saline (DPBS) to transfer remaining cells.
2. Filter the homogenate into a 50 mL conical tube through a 70 µm nylon mesh cell strainer to remove undigested tissue. Centrifuge strained cells for 5 min at 500 x g.
3. Dilute 10x RBC lysis buffer in sterile dH₂O to make a 1x working solution.
4. Aspirate the supernatant. Then resuspend the cell pellet in 10 mL of 1x RBC lysis buffer. Incubate for 5 min at 37 °C.
5. Add 20-25 mL of DPBS to neutralize the RBC lysis buffer and minimize lysis of salivary cells. Centrifuge for 5 min at 500 x g.
   NOTE: After treatment with RBC lysis buffer, the cell pellet should be white. Red color in the pellet indicates that not all RBC have been fully lysed. Repeat steps 4.4 through 4.5 if needed for complete lysis of all RBC.
6. Aspirate the supernatant. Resuspend the pellet in 1-2 mL of BEGM per well then place resuspended cells onto BMM-coated wells. Incubate at 37 °C.
7. Once plated on BMM, cells will form into spherical structures or "salispheres" over a 2-3-day period. Cells can be maintained as salispheres for about 5-7 days before the BMM begins to degrade allowing the cells to access and adhere to the plastic and grow as a monolayer.

5. Subculturing the salispheres and maintenance on BMM

1. Aspirate media from wells, then add 1 mL of dispase/collagenase solution to each well and incubate at 37 °C for ~15 min or until BMM has mostly dissolved.
2. Transfer cells to a 15 mL conical tube and wash wells once with DPBS to obtain remaining cells. Centrifuge for 5 min at 500 x g.
3. Aspirate the supernatant. Resuspend the pellet in 2 mL of trypsin then incubate at 37 °C for 15 min.
4. Neutralize the trypsin using any complete media containing 10% serum. Centrifuge for 5 min at 500 x g.
5. Aspirate the supernatant. Resuspend the cells in DPBS to remove residual media, trypsin, and serum. Centrifuge for 5 min at 500 x g.
6. Aspirate the supernatant. Resuspend in BEGM and plate the resuspended cells onto solidified BMM-coated culture dishes. Resuspended cells can also be plated directly onto cell culture treated dishes for proliferation as a monolayer. For more information regarding growth of salivary cells as a monolayer, see section 6. Cells grown on BMM or on plastic should be fed with fresh BEGM every 2–3 days.
7. Culture the cells in a humidified incubator maintained at 37 °C with 5% CO₂.

6. Subculturing the salispheres on treated plastic tissue culture dishes

NOTE: If maintaining cells as a monolayer on plastic, start at this step. The following protocol applies to cells growing in a 100 mm dish.

1. Aspirate the media. Wash once with DPBS to remove residual media.
2. Add 2 mL of trypsin then incubate at 37 °C for 15 min, or until cells have fully detached.
3. Neutralize trypsin using 4 mL of any complete media containing 10% serum. Transfer cells to a 15 mL conical tube.
4. Wash the plate once with approximately 5 mL of DPBS to collect remaining cells. Centrifuge for 5 min at 500 x g.
5. Aspirate the supernatant. Resuspend cells in 6-10 mL of DPBS to remove residual media.
6. Centrifuge for 5 min at 500 x g.
7. Aspirate the supernatant and resuspend in BEGM. Plate cells onto treated plastic tissue culture dishes. Feed with fresh BEGM every 2-3 days.
8. Culture the cells in a humidified incubator maintained at 37 °C with 5% CO₂.

7. Cryopreservation of cells

NOTE: Cryopreservation of cells can be accomplished from a single cell suspension originating from either salisphere or monolayer grown cells.

1. Count the cells on a hematocytometer to calculate total amount of cells present.
2. Centrifuge for 5 min at 500 x g.
3. Aspirate the supernatant. Resuspend the pellet in BEGM with 10% dimethyl sulfoxide (DMSO). Concentration of cells should be 2 x 10⁶ cells/mL to 10 x 10⁶ cells/mL.
4. Aliquot cells into sterile cryogenic storage tubes. Place the tubes in an insulated foam rack and incubate at -80 °C overnight to slowly freeze the cells.
5. On the next day, place tubes in liquid nitrogen for long term storage.
   NOTE: Cells should be rapidly thawed at 37 °C. Upon thawing, cells should be pelleted at 500 x g and the DMSO-containing media removed prior to plating.

Results

Two-three days after plating cells from digested tissue onto BMM, cells will readily form small clusters that will continue to expand in size up to 15-20 cells per cluster (Figure 2A). Cellular debris and detached dead cells are typically seen and should be removed by aspirating and replenishing with fresh media. Cells will continue to proliferate as salispheres for about 3-10 days, or as long as the BMM layer remains intact. Occasionally, due to partial brea...

Discussion

Salivary dysfunction represents a concern for the quality of life for those suffering from Sjögren's syndrome as well as those undergoing radiation therapy for cancers adjacent to the salivary glands^3,4,5,16. One proposed therapy to treat these patients is to grow functional salivary stem cells or organoids in vitro, which can then be inserted into damaged salivary gland to replace aff...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
100 mm culture dishes	Thermo Scientific	172931
15 mL conical tubes	Thermo Scientific	339651
50 mL conical tubes	Thermo Scientific	339653
Bronchial Epithelial Cell Growth Media	Lonza	CC-3171	Add bullet kit as per manufacturer's instructions. Supplement with 20 mL of charcoal stripped serum.
Cell strainer 70 µm nylon mesh	Fisher	22-363-548
Charcoal stripped fetal bovine serum	Gibco	12676-029
Collagenase type III	Worthington	LS004182	Store at 4 °C.
Cryogenic Tube	Fisher	5000-0020
Dispase	Cell Applications	07923	Dissolve collagenase to make a 0.15% (w/v) stock. Filter sterilize then store at -20 °C.
Dissecting scissors	Fisher	08-940
Dulbecco phosphate buffered saline	Corning	55-031-PC
General Chemicals	Sigma
PathClear Basement membrane extract	Cultrex	3432-005-01	Thaw at 4 °C at least 24 hr prior to use. Always handle on ice.
Six-well culture dishes	Falcon	353046
Surgical forceps	Fisher	22-079-742
Trypsin-EDTA solution	Corning	25-052-CI